Mitchell McLeod Pugh & Williams’s GSK GSK Stock Holding History

Mitchell McLeod Pugh & Williams’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,465	Closed	-$243K	–	231
2022 Q2	$243K	Hold	4,465	–	–	0.09%	188
2022 Q1	$243K	Hold	4,465	–	–	0.08%	203
2021 Q4	$246K	Hold	4,465	–	–	0.08%	206
2021 Q3	$213K	Hold	4,465	–	–	0.08%	211
2021 Q2	$222K	Buy	+4,465	New	+$215K	0.09%	210
2020 Q3	–	Sell	-3,976	Closed	-$203K	–	200
2020 Q2	$203K	Buy	+3,976	New	+$204K	0.12%	178

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return